Random Stream of Consciousness

Mornin,
images

44°and sunny! Beautiful!

Hope everyone has a great day!
 
Ok guys they are telling me that I need to take this new pain med and I'm hereing a lot of what I heard when told me to take oxy so does anyone have any information on it it is JOURNAVX TAB 50 MG (Suzetrigine) so if anyone has heard of it can you please share
No idea but Google search results as follows.

Suzetrigine (brand name Journavx) is a first-in-class, non-opioid oral pain medication approved by the FDA in January 2025 to treat moderate to severe acute short-term pain, such as post-surgical recovery. [1, 2]

How It Works
    • Target: Selectively blocks the \(\text{Na}_{\text{V}}1.8\) voltage-gated sodium channel in peripheral nociceptive neurons. [1]
    • Mechanism: Stops pain signals in the peripheral nervous system before they reach the brain and spinal cord. [1]
    • Safety Advantage: Lacks central nervous system activity, meaning it has no addictive potential, euphoria, sedation, or respiratory depression. [1, 2]

Dosage and Administration
    • Form: 50 mg oral tablets. [1]
    • Dosing Schedule: Typically 100 mg initially, followed by 50 mg every 12 hours (twice daily). [1]
    • Duration: Intended for short-term use, generally not exceeding 14 days. [1, 2]
    • Food Instructions: The first dose should be taken on an empty stomach (at least 1 hour before or 2 hours after food); subsequent doses can be taken with or without food. Tablets must be swallowed whole. [1]

Common Side Effects
    • Itching (pruritus)
    • Muscle spasms
    • Rash
    • Increased blood levels of creatine phosphokinase (CPK) [1]

Important Precautions
    • Liver Impairment: Metabolized by the liver via CYP3A enzymes; use is avoided in severe liver cirrhosis (Child-Pugh class C) and requires lower dosing in moderate impairment (Child-Pugh class B). [1, 2, 3]
    • Drug Interactions: Use with caution when taking moderate to strong CYP3A inhibitors. [1]
 
No idea but Google search results as follows.

Suzetrigine (brand name Journavx) is a first-in-class, non-opioid oral pain medication approved by the FDA in January 2025 to treat moderate to severe acute short-term pain, such as post-surgical recovery. [1, 2]

How It Works
    • Target: Selectively blocks the \(\text{Na}_{\text{V}}1.8\) voltage-gated sodium channel in peripheral nociceptive neurons. [1]
    • Mechanism: Stops pain signals in the peripheral nervous system before they reach the brain and spinal cord. [1]
    • Safety Advantage: Lacks central nervous system activity, meaning it has no addictive potential, euphoria, sedation, or respiratory depression. [1, 2]

Dosage and Administration
    • Form: 50 mg oral tablets. [1]
    • Dosing Schedule: Typically 100 mg initially, followed by 50 mg every 12 hours (twice daily). [1]
    • Duration: Intended for short-term use, generally not exceeding 14 days. [1, 2]
    • Food Instructions: The first dose should be taken on an empty stomach (at least 1 hour before or 2 hours after food); subsequent doses can be taken with or without food. Tablets must be swallowed whole. [1]

Common Side Effects
    • Itching (pruritus)
    • Muscle spasms
    • Rash
    • Increased blood levels of creatine phosphokinase (CPK) [1]

Important Precautions
    • Liver Impairment: Metabolized by the liver via CYP3A enzymes; use is avoided in severe liver cirrhosis (Child-Pugh class C) and requires lower dosing in moderate impairment (Child-Pugh class B). [1, 2, 3]
    • Drug Interactions: Use with caution when taking moderate to strong CYP3A inhibitors. [1]
Thanks for the info I do appreciate it
 
Back
Top